TY - JOUR
T1 - Closing the Gaps in Racial Disparities in Critical Limb Ischemia Outcome and Amputation Rates
T2 - Proceedings from a Society of Interventional Radiology Foundation Research Consensus Panel
AU - Bryce, Yolanda
AU - Katzen, Barry
AU - Patel, Parag
AU - Moreira, Carla C.
AU - Fakorede, Foluso A.
AU - Arya, Shipra
AU - D'Andrea, Melissa
AU - Mustapha, Jihad
AU - Rowe, Vincent
AU - Rosenfield, Kenneth
AU - Vedantham, Suresh
AU - Abi-Jaoudeh, Nadine
AU - Rochon, Paul J.
N1 - Funding Information:
Y.B. reports consulting fees from Hologic, Inc., and award grants from Bristol Myers Squibb Foundation and Diagnosis Quality Improvement. B.K. reports consulting fees from Boston Scientific, WL Gore, and Philips and travel support from and participation on a Data Safety Monitoring Board for WL Gore. P.P. reports payments from Penumbra and participation on a Data Safety Monitoring Board or Advisory Board for Boston Scientific, Medtronic, and Cordis. C.C.M. reports support from Silk Road Medical, Inc., and Podiatry Institute. S.A. reports research and development grant from VA Health Services (1I01HX003215-01A1). M.D. reports student research fellowship grant of $3,000 from SVS. J.M. reports consulting fees from Angiodynamic, Avinger, Bard Peripheral Vascular, Boston Scientific, Cardiovascular Systems, Inc., Medtronic, Philips, Terumo, PQ Bypass, Cardioflow, and Micromedical Solutions. K.R. reports support from Access Vascular, Angiodynamics, Althea Medical, Contego, Philips, Boston Scientific, Penumbra, Surmodics, Janssen, Neptune Medical, Inspire MD, Magneto, Mayo Clinic, BMS-Pfizer, Summa Therapeutic, Thrombolex, Truvic, National Institutes of Health, Intact Vascular, Accolade, Capture Vascular, Cruzar Systems, Embolitech, Endospan, Eximo, JanaCare, Magnet, Micell, Orgestra, PQ Bypass, Shockwave Medical, Summa Therapeutics, Thrombolex, Truvic, Valcare, and National PERT Consortium. S.V. has been a member of the Data Safety Monitoring Board for National Institutes of Health–funded BEST-CLI trial. N.A.-J. reports research grants from Philips Medical Systems Inc., Teclison Inc., Guerbet Inc., Sillajen Inc., Instylla HES, Blackswan Vascular Inc., and SIRTEX Inc.; is the owner in Bruin Biosciences Inc.; and is on the advisory board for Genetech Roch, QED Therapeutics Inc., Eisai, Medtronic, Pfizer, and Johnson and Johnson. P.J.R. reports support from Medtronic and Penumbra. None of the other authors have identified a conflict of interest.
Funding Information:
This article is an SIR Foundation–sponsored white paper.
Publisher Copyright:
© 2022 SIR
PY - 2022/5
Y1 - 2022/5
N2 - Minority patients such as Blacks, Hispanics, and Native Americans are disproportionately impacted by critical limb ischemia and amputation due to multiple factors such as socioeconomic status, type or lack of insurance, lack of access to health care, capacity and expertise of local hospitals, prevalence of diabetes, and unconscious bias. The Society of Interventional Radiology Foundation recognizes that it is imperative to close the disparity gaps and funded a Research Consensus Panel to prioritize a research agenda. The following research priorities were ultimately prioritized: (a) randomized controlled trial with peripheral arterial disease screening of at-risk patients with oversampling of high-risk racial groups, (b) prospective trial with the introduction of an intervention to alter a social determinant of health, and (c) a prospective trial with the implementation of an algorithm that requires criteria be met prior to an amputation. This article presents the proceedings and recommendations from the panel.
AB - Minority patients such as Blacks, Hispanics, and Native Americans are disproportionately impacted by critical limb ischemia and amputation due to multiple factors such as socioeconomic status, type or lack of insurance, lack of access to health care, capacity and expertise of local hospitals, prevalence of diabetes, and unconscious bias. The Society of Interventional Radiology Foundation recognizes that it is imperative to close the disparity gaps and funded a Research Consensus Panel to prioritize a research agenda. The following research priorities were ultimately prioritized: (a) randomized controlled trial with peripheral arterial disease screening of at-risk patients with oversampling of high-risk racial groups, (b) prospective trial with the introduction of an intervention to alter a social determinant of health, and (c) a prospective trial with the implementation of an algorithm that requires criteria be met prior to an amputation. This article presents the proceedings and recommendations from the panel.
UR - http://www.scopus.com/inward/record.url?scp=85129199990&partnerID=8YFLogxK
U2 - 10.1016/j.jvir.2022.02.010
DO - 10.1016/j.jvir.2022.02.010
M3 - Article
C2 - 35489789
AN - SCOPUS:85129199990
SN - 1051-0443
VL - 33
SP - 593
EP - 602
JO - Journal of Vascular and Interventional Radiology
JF - Journal of Vascular and Interventional Radiology
IS - 5
ER -